Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-09-15
著者
-
Reiter Andrea
Iii. Medizinische Klinik Medizinische Fakultat Mannheim Der Universitat Heidelberg
-
Li Chi-cheng
Department Of Oncology-hematology Tzu Chi General Hospital
-
Wang Tso-fu
Department Of Oncology-hematology Tzu Chi General Hospital
-
Chase Andrew
Wessex Regional Genetics Laboratory Salisbury District Hospital
-
HUANG Kuan-Po
Department of Oncology-Hematology, Tzu Chi General Hospital
-
HUANG Kuan-Po
Division of Oncology and Hematology, Buddhist Tzu Chi General Hospital
-
CROSS Nicholas
Wessex Regional Genetics Laboratory, Salisbury District Hospital
-
LI Tzu-Ying
Cytogenetics Laboratory, Center for Medical Genetics, Buddhist Tzu Chi General Hospital and Tzu Chi
-
WANG Tso-Fu
Division of Oncology and Hematology, Buddhist Tzu Chi General Hospital
-
CHU Sung-Chao
Division of Oncology and Hematology, Buddhist Tzu Chi General Hospital
-
LU Xuan-Yin
Division of Oncology and Hematology, Buddhist Tzu Chi General Hospital
-
LI Chi-Cheng
Division of Oncology and Hematology, Buddhist Tzu Chi General Hospital
-
KAO Ruey-Ho
Division of Oncology and Hematology, Buddhist Tzu Chi General Hospital
-
Huang Kuan-po
Department Of Oncology-hematology Tzu Chi General Hospital
-
Cross Nicholas
Wessex Regional Genetics Laboratory Salisbury District Hospital
-
Chu Sung-chao
Department Of Oncology-hematology Tzu Chi General Hospital
-
Kao Ruey-ho
Department Of Oncology-hematology Tzu Chi General Hospital
-
Li Tzu-ying
Cytogenetics Laboratory Center For Medical Genetics Buddhist Tzu Chi General Hospital And Tzu Chi Un
-
Lu Xuan-yin
Division Of Oncology And Hematology Buddhist Tzu Chi General Hospital
関連論文
- Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia
- Correlation between characteristics of unrelated bone marrow donor and cell density of total nucleated cell in bone marrow harvest
- The role of donor characteristics and post-granulocyte colony-stimulating factor white blood cell counts in predicting the adverse events and yields of stem cell mobilization